Coronavirus Update: New Clinical Trials Network Could Help Pick Vaccine, Antibody Winners Faster
Launched By Operation Warp Speed
Plus: the World Health Organization has commissioned an independent panel to look at pandemic responses, while the emergence of an unknown pneumonia in Kazakstan is causing concern.
You may also be interested in...
Dozens of specially outfitted RVs will roll out to long-term care facilities in the US to test the prophylactic and symptom-reducing potential of the antibody Lilly is developing with AbCellera.
Operation Warp Speed extends its funding beyond vaccines into antibodies, while insiders say friction between Moderna and US government scientists has caused delays.
Europe has granted a conditional approval to Gilead’s drug, now named Veklury, costing €2,000 per treatment.